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Arboviruses are arthropod-borne viruses, which include West Nile 
fever virus (WNFV), a mosquito-borne virus, Rift Valley fever virus 
(RVFV), a mosquito-borne virus, and Crimean-Congo haemorrhagic 
fever virus (CCHFV), a tick-borne virus. These arthropod-borne 
viruses can cause disease in different domestic and wild animals 
and in humans, posing a threat to public health because of their 
epidemic and zoonotic potential. In recent decades, the geographical 
distribution of these diseases has expanded. Outbreaks of WNF 
have already occurred in Europe, especially in the Mediterranean 
basin. Moreover, CCHF is endemic in many European countries 
and serious outbreaks have occurred, particularly in the Balkans, 
Turkey and Southern Federal Districts of Russia. In 2000, RVF 
was reported for the first time outside the African continent, with 
cases being confirmed in Saudi Arabia and Yemen. This spread was 
probably caused by ruminant trade and highlights that there is a 
threat of expansion of the virus into other parts of Asia and Europe. 
In the light of global warming and globalisation of trade and travel, 
public interest in emerging zoonotic diseases has increased. This 
is especially evident regarding the geographical spread of vector-
borne diseases. A multi-disciplinary approach is now imperative, 
and groups need to collaborate in an integrated manner that 
includes vector control, vaccination programmes, improved therapy 
strategies, diagnostic tools and surveillance, public awareness, 
capacity building and improvement of infrastructure in endemic 
regions.
Concept and objectives
West Nile fever virus (WNFV), Rift Valley fever virus (RVFV) and 
Crimean-Congo haemorrhagic fever virus (CCHFV) are arthropod-
borne viruses that infect different domestic and wild animals 
and can also cause disease in humans [1-3]. Their geographical 
distribution has expanded over recent decades. WNF outbreaks 
have already occurred in Europe (Romania, Bulgaria, Italy and 
France) [4-6]. CCHF is endemic in many countries in Africa, Europe 
and Asia, and since 1999, cases or outbreaks have been recorded 
in Kosovo [7], Albania [8], Bulgaria [9], Greece [10], Iran, Pakistan, 
South Africa, and the Southern Federal Districts of Russia [11] as 
well as in Turkey [12-14]. RVF is present in a number of African 
countries. In September 2000, RVF was reported for the first 
time outside the African continent. Since then, cases have been 
confirmed in Saudi Arabia and Yemen [15]. This introduction of 
the epidemic to the Arabian Peninsula highlights that there is a 
threat of expansion into other parts of Asia and Europe. In 2007, 
an outbreak of RFV occurred in Kenya, Somalia and Tanzania and 
has recently expanded to Madagascar and South Africa in 2008 
[16,17].
There is a public interest regarding emerging zoonotic diseases 
and information is required to explain the presence of “disease hot-
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spots” in Europe. It is therefore imperative to work out integrated 
control measures which include:
• Vector control, including surveillance of naturally occurring 
vector populations and their suitability for transmission, 
• Vaccination programmes, 
• Improved therapy strategies, 
• Improvement of diagnostic tools and surveillance, 
• Public awareness campaigns, 
• Capacity building and improvement of infrastructure in endemic 
regions.
The recent CCHF outbreak in Turkey is of particular interest. It 
was first recognised as an outbreak with thirteen cases in 2002. The 
total number of confirmed cases has since risen to 2,974 (reported 
between 2002 and 2008), including 146 deaths [12,13]. Although 
the exact data are not available, a similar situation is seen in the 
Southern Federal Districts of Russia, where the outbreak started 
in 1999. In response to this situation, the European Commission 
has included issues related to these diseases in its framework 
programme 7 (FP 7). In addition, the recent outbreaks of CCHF 
have prompted the World Health Organization (WHO) to take 
action in the form of a “Joint WHO-MZCP Intercountry Workshop 
on Crimean-Congo Haemorrhagic fever (CCHF) Prevention and 
Control”, jointly organised by the Mediterranean Zoonoses Control 
Programme (MZCP), the Eastern Mediterranean Regional Office 
(EMRO), the Regional Office for Europe and the WHO headquarters, 
in collaboration with the World Organisation for Animal Health 
(OIE), the Food and Agriculture Organization of the United Nations 
(FAO/UN) and the Integrated Consortium on Ticks and Tick-borne 
Diseases (ICTTD-3). The workshop was held in Istanbul, Turkey 
on 6-8 November 2006. The meeting recognised that “CCHF 
outbreaks constitute a threat to public health services because 
of their epidemic potential, its high case fatality rate (5-40%), its 
potential for nosocomial outbreaks and the difficulties in treatment 
and prevention”.
During a meeting on RVFV, held by the Atomic Energy Agency in 
Nairobi on 5-9 March 2007, scientific representatives from African 
countries and Yemen, where the virus circulates, shared information 
and data on RVF surveillance.
Until the end of the 1990s, WNF was considered a minor risk 
to human health as the virus appeared only sporadically. Since 
1996, the year of the first large outbreak in Romania [18], WNFV 
has become a major public health and veterinary concern in Europe 
and in the Mediterranean Basin, because new endemic foci have 
appeared. In the United States, an epidemic was first noted in New 
York City in 1999. Since then, more than 25,000 human cases 
and more than 15,000 equine cases have been reported [19]. 
In France, WNFV outbreaks occurred in 2000 (76 cases and 21 
deaths in horses), 2003 (seven human cases and seven equine 
cases), 2004 (32 equine cases) and 2006 (five equine cases). 
In 2008, the first indigenous human WNFV cases were reported 
in Italy [20], and an increased number of cases was observed in 
the same year in Hungary [21]. In this context, there is an urgent 
need to improve serological tests and molecular tools for the rapid 
diagnosis of WNFV.
To this end, the ARBO-ZOONET project specifically promotes:
• Sharing knowledge of these diseases, exchanging data and 
expertise, improving the flow of scientific information,
• Maintaining and expanding surveillance systems, monitoring 
disease occurrence, virus isolation and vaccine use,
• Introducing and distributing tools for disease detection and 
control; creating common standards,
• Disseminating knowledge and organising training for staff of 
international organisations and relevant countries outside the 
European Union (EU), in particular those where these diseases 
represent a major threat to the EU as well as those that are 
particularly active in research,
• Interlinking different scientific disciplines.
Work plan
The work plan of ARBO-ZOONET foresees a number of inter-
related tasks, with measurable deliverables and milestones. 
Specifically, the plan aims at:
1. Identifying risk areas and undertaking the necessary 
preparatory work for updated risk maps on RVF, WNF and CCHF 
introduction and/or spread throughout the EU territory. Efforts will 
focus on understanding the ecology of host, vectors and disease 
reservoir. Moreover, this task will produce maps and estimate the 
numbers of vectors in order to prepare models for policy makers.
2. Collection and preservation of biologically diverse pathogens 
is an essential pre-requisite for the improvement and harmonisation 
of diagnostic tests as well as for vaccine design. In addition, the 
availability of pure pathogen material is essential for the molecular 
characterisation of different isolates including their sequence and 
determination of pathogenicity and virulence. The establishment 
of pathogen bank facilities at regional reference laboratories is 
urgently required. This co-ordinated action will create a pathogen 
database open to the scientific community that will contain 
information on where live samples of a given pathogen are available. 
This database will include other biological material such as serum 
and genetic material from different geographical areas where the 
relevant diseases are endemic.
3. Surveillance networks will be established for the collection of 
global data on the occurrence of RVF, WNF and CCHF. An essential 
task of this project is reporting on the analysis of the RVF, WNF 
and CCHF surveillance systems for the EU and for affected areas in 
countries outside the EU. These analyses will be used to establish 
adequate georeferenced data and to derive spatial conclusions. 
The assessment will address significant aspects of the surveillance 
and control activities (monitoring approaches, diagnostic methods 
and capabilities, established information systems, data analysis 
capabilities, geographic distribution of virus strains, vector 
competence studies, entomological expertise and surveillance 
methods applied, protocols for vaccine use) to serve as a framework 
for shared datasets.
4.Moreover, working groups will be established to assess data 
focused on vector control, vaccination and therapy. The proposed 
project will act as a platform to bring together those participants who 
are actively involved in molecular vaccine development. Emphasis 
will be given to integrated vaccine strategies using vaccines 
based on pathogen and vector components and development of 
appropriate delivery systems. In this context, studies on molecular 
characterisation the interaction between host, vector and pathogen 
will be promoted, primarily through scientific exchange visits. 
Therapeutic options will also be examined. This will be done either 
by working on existing pharmaceuticals or by developing new ones. 
5. The principal focus of the project is the transfer of knowledge 
and technology between the members of the consortium, which 
includes partners from relevant countries outside the EU. In this 
context, links will be established to the national and international 
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organisations (WHO, FAO, OIE, or the International Regional 
Organization for Plant and Animal Health (OIRSA)), institutions and 
laboratories located in the different areas in order to disseminate 
and transfer technologies needed to develop strategies for 
integrated control measures in endemic regions such as diagnostics, 
epidemiology and economic dimension of a number of endemic as 
well as epizootic animal diseases.
6. ARBO-ZOONET will play a co-ordinating role a within the EU’s 
Animal Health Strategy by bringing together interested members 
of other EU consortia that share the focus on zoonoses caused 
by vector-borne arboviruses, such as the Emerging Diseases in a 
changing European eNvironment (EDEN) project, the Network of 
Excellence for Epizootic Disease Diagnosis and Control (Epizone), 
and the Environmental Vulnerability Assessment (EVA) project.
The strategy of technology transfer (see Figure) is to train the 
staff in the use of tools and technologies required for:
• Specific and effective detection and differentiation of the 
pathogens causing the above diseases,
• Professional epidemiological studies,
• Effective control strategies, and
• Better disease outbreak management.
As a first step, pre-educated staff from countries outside the EU 
will be selected to be trained as trainers in different EU laboratories 
specialised in viral diseases, especially in those that have been 
recognised by the WHO as reference laboratories based on the 
availability of knowledge and the required infrastructure. As a 
second step, these trainers will then organise training courses in 
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their own countries in close cooperation and coordination with task 
forces to be established for this purpose.
The ARBO-ZOONET project is well integrated in international 
cooperating networks. In this context, joint meetings and activities 
in the field of disease surveillance and monitoring will be organised 
and the project will seek to cooperate with the European Centre for 
Disease Prevention and Control (ECDC) in this.
Conclusions
The project deals with three viruses considered to be emerging 
in Europe, although it is established that other arboviruses are 
also emerging. Knowledge gained in the course of this project may 
thus be relevant for other diseases and will be transferred to other 
networks dealing with these. In addition, experts on other vector-
borne diseases will be invited to participate in ARBO-ZOONET 
activities.
An important aspect of this project will be that human and 
veterinary health authorities as well as veterinary education centres 
and faculties will work together in order to achieve the goals of the 
technology transfer.
Aknowledgements
Vivamus tempor mi quis quam. Fusce tempus, ante sed tincidunt ornare, 
nisi urna viverra enim, eget venenatis dui ante ut eros.
References
1. Blitvich BJ. Transmission dynamics and changing epidemiology of West Nile 
virus. Anim Health Res Rev. 2008;9(1):71-86. 
2. Flick R, Bouloy M. Rift Valley fever virus. Curr Mol Med. 2005;5(8):827-34. 
3. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 
2006;6(4):203-14. 
4. Savage HM, Ceianu C, Nicolescu G, Karabatsos N, Lanciotti R, Vladimirescu 
A, et al. Entomologic and avian investigations of an epidemic of West Nile 
fever in Romania in 1996, with serologic and molecular characterization of 
a virus isolate from mosquitoes. Am J Trop Med Hyg. 1999;61(4):600-11 
5. Durand B, Chevalier V, Pouillot R, Labie J, Marendat I, Murgue B, et al. West 
Nile virus outbreak in horses, southern France, 2000: results of a serosurvey. 
Emerg Infect Dis. 2002;8(8):777-82. 
6. Autorino GL, Battisti A, Deubel V, Ferrari G, Forletta R, Giovannini A, et al. 
West Nile virus epidemic in horses, Tuscany region, Italy. Emerg Infect Dis. 
2002;8(12):1372-8. 
7. Ahmeti S, Raka L. Crimean-Congo haemorrhagic fever in Kosova: a fatal case 
report. Virol J. 2006;3:85. 
8. Papa A, Bino S, Llagami A, Brahimaj B, Papadimitriou E, Pavlidou V, et al. 
Crimean-Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect 
Dis. 2002;21(8):603-6. 
9. Kunchev A, Kojouharova M. Probable cases of Crimean-Congo-haemorrhagic 
fever in Bulgaria: a preliminary report. Euro Surveill. 2008;13(17):pii=18845. 
Available from: http://www.eurosurveillance.org/ViewArticle.
aspx?ArticleId=18845 
10. Papa A, Maltezou HC, Tsiodras S, Dalla VG, Papadimitriou T, Pierroutsakos I, et 
al. A case of Crimean-Congo haemorrhagic fever in Greece, June 2008. Euro 
Surveill. 2008;13(33):pii=18952. Available from: http://www.eurosurveillance.
org/ViewArticle.aspx?ArticleId=18952 
11. Butenko AM, Korganova GG. Crimean-Congo Hemorrhagic Fever in Russia and 
Other Countries of the Former Soviet Union. In: O Ergonul,C Whitehouse, 
editors. Crimean-Congo Haemorrhagic Fever, A Global Perspective. Dordrecht: 
Springer; 2007. p.99-114. 
12. Yilmaz GR, Buzgan T, Torunoglu MA, Safran A, Irmak H, Com S, et al. A 
preliminary report on Crimean-Congo haemorrhagic fever in Turkey, March - 
June 2008. Euro Surveill. 2008;13(33):pii=18953. Available from: http://www.
eurosurveillance.org/ViewArticle.aspx?ArticleId=18953 
13. Ergonul O. The Role of ARBO-ZOONET in Crimean-Congo Hemorrhagic Fever. 
ARBO-ZOONET News 2009;2:5-6. 
14. Estrada-Peña A, Zatansever Z, Gargili A, Aktas M, Uzun R, Ergonul O, et al. 
Modeling the spatial distribution of crimean-congo hemorrhagic fever 
outbreaks in Turkey. Vector Borne Zoonotic Dis. 2007;7(4):667-78. 
15. Abdo-Salem S, Gerbier G, Bonnet P, Al-Qadasi M, Tran A, Thiry E, et al. 
Descriptive and spatial epidemiology of Rift valley fever outbreak in Yemen 
2000-2001. Ann N Y Acad Sci. 2006;1081:240-2. 
16. Bird BH, Githinji JW, Macharia JM, Kasiiti JL, Muriithi RM, Gacheru SG, et al. 
Multiple virus lineages sharing recent common ancestry were associated with 
a large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. 
J Virol. 2008;82(22):11152-66. 
17. Paweska J, Blumberg L, Weyer J, Kemp A, Leman P, Archer B, et al. Rift Valley 
fever outbreak in South Africa, 2008. NICD-NHLS Communicable Diseases 
Surveillance Bulletin.2008;6(2):1-2. 
18. Campbell GL, Ceianu CS, Savage HM. Epidemic West Nile encephalitis 
in Romania: waiting for history to repeat itself. Ann N Y Acad Sci. 
2001;951:94-101. 
19. Zeller HG, Schuffenecker I. West Nile virus: an overview of its spread in 
Europe and the Mediterranean basin in contrast to its spread in the Americas. 
Eur J Clin Microbiol Infect Dis. 2004;23(3):147-56. 
20. Rossini G, Cavrini F, Pierro A, Macini P, Finarelli A, Po C, et.al. First human 
case of West Nile virus neuroinvasive infection in Italy, September 2008 - 
case report. Euro Surveill. 2008;13(41). pii: 19002. Available from: http://www.
eurosurveillance.org/ViewArticle.aspx?ArticleId=19002 
21. Krisztalovics K, Ferenczi E, Molnár Z, Csohán Á, Bán E, Zöldi V, et al. West 
Nile virus infections in Hungary, August-September 2008. Euro Surveill. 
2008;13(45):pii: 19030. Available from: http://www.eurosurveillance.org/
ViewArticle.aspx?ArticleId=19030
This article was published on 26 March 2009.
Citation style for this article: Ahmed J, Bouloy M, Ergonul O, Fooks AR, Paweska J, 
Chevalier V, Drosten C, Moormann R, Tordo N, Vatansever Z, Calistri P, Estrada-Peña 
A, Mirazimi A, Unger H, Yin H, Seitzer U. International network for capacity building 
for the control of emerging viral vector-borne zoonotic diseases: ARBO-ZOONET. Euro 
Surveill. 2009;14(12):pii=19160. Available online: http://www.eurosurveillance.org/
ViewArticle.aspx?ArticleId=19160 
